Acadia Pharmaceuticals | ACAD - Stock





Stock Veränderung Datum
Acadia Pharmaceuticals USD 108.67M 77.1M 2026-06
ALKERMES USD 298.96M 37.75M 2026-06
Alnylam Pharmaceuticals USD 97.11M 103.04M 2026-06
Biogen USD 2.38B 435.3M 2026-06
BioMarin Pharmaceutical USD 1.78B 509.3M 2026-06
Bristol-Myers Squibb USD 2.74B 19M 2026-06
Cara Therapeutics USD 900K 0 2025-03
Corcept Therapeutics USD 13.18M 295K 2026-06
Cytokinetics USD 380K 226K 2026-06
Eisai JPY 257.55B 21.09B 2026-03
Eli Lilly USD 16.79B 2.26B 2026-06
Incyte USD 112.54M 3.08M 2026-06
J&J USD 15.14B 561M 2026-06
Moderna USD 280M 134M 2026-06
Neurocrine Biosciences USD 104.2M 39.7M 2026-06
Pfizer USD 9.94B 722M 2026-06
PTC Therapeutics USD 91.35M 15.79M 2026-06
Sarepta Therapeutics USD 904.27M 96.84M 2026-06
Ultragenyx Pharmaceutical USD 59M 4M 2026-06
Vanda Pharmaceuticals USD 1.85M 190K 2025-12
Vertex Pharmaceuticals USD 1.77B 1.6M 2026-06